Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness

BACKGROUND: In a prospective study with long-term follow-up, we analyzed circulating T cell subsets in patients with metastatic colorectal cancer (mCRC) in the context of primary tumor sidedness, KRAS status, and clinical outcome. Our primary goal was to investigate whether baseline levels of circul...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Bencsikova, Beatrix, Budinska, Eva, Selingerova, Iveta, Pilatova, Katerina, Fedorova, Lenka, Greplova, Kristina, Nenutil, Rudolf, Valik, Dalibor, Obermannova, Radka, Sheard, Michael A., Zdrazilova-Dubska, Lenka
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6631500/
https://ncbi.nlm.nih.gov/pubmed/31307428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5909-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires